Lisa Schnirring | News Editor | CIDRAP NewsNov 18, 2020The protection is even better than the 90% found in an initial analysis.
Pfizer-BioNTech note 95% COVID vaccine efficacy, will apply for EUA
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Global health groups propose new terminology for pathogens that spread through the air
- COVID vaccination in kids protects against serious outcomes, but it wanes over time, new data show
- Severe COVID in older adults may be due to greater viral load, weaker immune response
- Study: Time to walk, drive to COVID vaccination sites may have deterred some